{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:06:09Z","timestamp":1791302769437,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10067-014-2754-4","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T09:20:22Z","timestamp":1407921622000},"page":"1611-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy"],"prefix":"10.1007","volume":"33","author":[{"given":"Fei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Gilkeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"issue":"26","key":"2754_CR1","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM199406303302608","volume":"330","author":"JA Mills","year":"1994","unstructured":"Mills JA (1994) Systemic lupus erythematosus. N Engl J Med 330(26):1871\u20131879","journal-title":"N Engl J Med"},{"issue":"20","key":"2754_CR2","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1001\/archinte.160.20.3136","volume":"160","author":"MM Ward","year":"2000","unstructured":"Ward MM (2000) Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 160(20):3136\u20133140","journal-title":"Arch Intern Med"},{"issue":"10","key":"2754_CR3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","volume":"314","author":"HA Austin 3rd","year":"1986","unstructured":"Austin HA 3rd, Klippel JH, Balow JE et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314(10):614\u2013619","journal-title":"N Engl J Med"},{"issue":"8822","key":"2754_CR4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","volume":"340","author":"DT Boumpas","year":"1992","unstructured":"Boumpas DT, Austin HA 3rd, Vaughn EM et al (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340(8822):741\u2013745","journal-title":"Lancet"},{"issue":"8","key":"2754_CR5","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D et al (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46(8):2121\u20132131","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2754_CR6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/0961203309106921","volume":"18","author":"G Zandman-Goddard","year":"2009","unstructured":"Zandman-Goddard G, Blank M, Shoenfeld Y (2009) Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus 18(10):884\u2013888","journal-title":"Lupus"},{"issue":"7","key":"2754_CR7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Jayne","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18(7):2180\u20132188","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2754_CR8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1681\/ASN.2007121272","volume":"19","author":"H Bao","year":"2008","unstructured":"Bao H, Liu ZH, Xie HL, Hu WX, Zhang HT, Li LS (2008) Successful treatment of class V\u2009+\u2009IV lupus nephritis with multitarget therapy. J Am Soc Nephrol 19(10):2001\u20132010","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2754_CR9","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1681\/ASN.2008070779","volume":"19","author":"RJ Glassock","year":"2008","unstructured":"Glassock RJ (2008) Multitarget therapy of lupus nephritis: base hit or home run? J Am Soc Nephrol 19(10):1842\u20131844","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2754_CR10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2011.04.032","volume":"10","author":"GJ Pons-Estel","year":"2011","unstructured":"Pons-Estel GJ, Serrano R, Plas\u00edn MA, Espinosa G, Cervera R (2011) Epidemiology and management of refractory lupus nephritis. Autoimmun Rev 10(11):655\u2013663","journal-title":"Autoimmun Rev"},{"issue":"9","key":"2754_CR11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ncprheum0896","volume":"4","author":"G Bertsias","year":"2008","unstructured":"Bertsias G, Boumpas DT (2008) Update on the management of lupus nephritis: let the treatment fit the patient. Nat Clin Pract Rheumatol 4(9):464\u2013472","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"4","key":"2754_CR12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0961203311426569","volume":"21","author":"M Aringer","year":"2012","unstructured":"Aringer M, Burkhardt H, Burmester GR et al (2012) Current state of evidence on \u201coff label\u02ee therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria, and Switzerland\u2014a consensus report. Lupus 21(4):386\u2013401","journal-title":"Lupus"},{"issue":"5","key":"2754_CR13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","volume":"295","author":"RK Burt","year":"2006","unstructured":"Burt RK, Traynor A, Statkute L et al (2006) Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295(5):527\u2013535","journal-title":"JAMA"},{"issue":"7","key":"2754_CR14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1681\/ASN.2010050559","volume":"21","author":"A Nagy","year":"2010","unstructured":"Nagy A, Quaggin SE (2010) Stem cell therapy for the kidney: a cautionary tale. J Am Soc Nephrol 21(7):1070\u20131072","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2754_CR15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","volume":"5","author":"F Djouad","year":"2009","unstructured":"Djouad F, Bouffi C, Ghannam S, No\u00ebl D, Jorgensen C (2009) Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheum 5(7):392\u2013399","journal-title":"Nat Rev Rheum"},{"issue":"4","key":"2754_CR16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2010.09.009","volume":"7","author":"K English","year":"2010","unstructured":"English K, French A, Wood K (2010) Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7(4):431\u2013442","journal-title":"Cell Stem Cell"},{"issue":"8","key":"2754_CR17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","volume":"69","author":"J Liang","year":"2010","unstructured":"Liang J, Zhang H, Hua B et al (2010) Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69(8):1423\u20131429","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2754_CR18","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J et al (2010) Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62(8):2467\u20132475","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2754_CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Chen C, Wang D et al (2012) Mesenchymal stem cell induced immunoregulation involves Fas Ligand\/Fas-mediated T cell apoptosis. Cell Stem Cell 10(5):544\u2013555","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2754_CR20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","volume":"70","author":"D Wang","year":"2011","unstructured":"Wang D, Zhang H, Cao M et al (2011) Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Ann Rheum Dis 70(7):1285\u20131288","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2754_CR21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1352458509104590","volume":"15","author":"J Liang","year":"2009","unstructured":"Liang J, Zhang H, Hua B et al (2009) Allogenic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 15(5):644\u2013646","journal-title":"Mult Scler"},{"issue":"3","key":"2754_CR22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gutjnl-2011-300083","volume":"61","author":"J Liang","year":"2012","unstructured":"Liang J, Zhuang H, Wang D et al (2012) Allogenic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease. Gut 61(3):468\u2013469","journal-title":"Gut"},{"issue":"1","key":"2754_CR23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","volume":"31","author":"J Liang","year":"2012","unstructured":"Liang J, Li X, Zhang H et al (2012) Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol 31(1):157\u2013161","journal-title":"Clin Rheumatol"},{"issue":"8","key":"2754_CR24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1191\/096120399680411317","volume":"8","author":"EL Smith","year":"1999","unstructured":"Smith EL, Shmerling RH (1999) The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 8(8):586\u2013595","journal-title":"Lupus"},{"issue":"2","key":"2754_CR25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241\u2013250","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"2754_CR26","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","volume":"353","author":"EM Ginzler","year":"2005","unstructured":"Ginzler EM, Dooley MA, Aranow C et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353(21):2219\u20132228","journal-title":"N Engl J Med"},{"issue":"12","key":"2754_CR27","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1136\/ard.2010.131995","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, D\u2019Cruz D, Sangle S et al (2010) Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial. Ann Rheum Dis 69(12):2083\u20132089","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2754_CR28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/rheumatology\/34.3.257","volume":"34","author":"MR Ehrenstein","year":"1995","unstructured":"Ehrenstein MR, Conroy SE, Heath J, Latchman DS, Isenberg DA (1995) The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. Br J Rheumatol 34(3):257\u2013260","journal-title":"Br J Rheumatol"},{"issue":"7308","key":"2754_CR29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S M\u00e9ndez-Ferrer","year":"2010","unstructured":"M\u00e9ndez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466(7308):829\u2013834","journal-title":"Nature"},{"key":"2754_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","volume":"6","author":"NG Singer","year":"2011","unstructured":"Singer NG, Caplan AI (2011) Mesenchymal stem cells: mechanisms of inflammation. Ann Rev Pathol 6:457\u2013478","journal-title":"Ann Rev Pathol"},{"issue":"10","key":"2754_CR31","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10):3499\u20133506","journal-title":"Blood"},{"issue":"12","key":"2754_CR32","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.intimp.2010.06.019","volume":"10","author":"MJ Hoogduijn","year":"2010","unstructured":"Hoogduijn MJ, Popp F, Verbeek R et al (2010) The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharm 10(12):1496\u20131500","journal-title":"Int Immunopharm"},{"issue":"6","key":"2754_CR33","first-page":"1035","volume":"14","author":"MB Herrera","year":"2004","unstructured":"Herrera MB, Bussolati B, Bruno S et al (2004) Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14(6):1035\u20131041","journal-title":"Int J Mol Med"},{"issue":"8","key":"2754_CR34","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1089\/scd.2009.0196","volume":"19","author":"K Li","year":"2010","unstructured":"Li K, Han Q, Yan X, Liao L, Zhao RC (2010) Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing. Stem Cells Dev 19(8):1267\u20131275","journal-title":"Stem Cells Dev"},{"issue":"11","key":"2754_CR35","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J, Wu W, Xu X et al (2012) Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307(11):1169\u20131177","journal-title":"JAMA"},{"issue":"2","key":"2754_CR36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3727\/096368910X520056","volume":"20","author":"JW Chang","year":"2011","unstructured":"Chang JW, Hung SP, Wu HH et al (2011) Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant 20(2):245\u2013257","journal-title":"Cell Transplant"},{"issue":"1","key":"2754_CR37","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F T\u00f6gel","year":"2005","unstructured":"T\u00f6gel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289(1):F31\u2013F42","journal-title":"Am J Physiol Renal Physiol"},{"issue":"13","key":"2754_CR38","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/0961203310373782","volume":"19","author":"Z Gu","year":"2010","unstructured":"Gu Z, Akiyama K, Ma X et al (2010) Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL\/lpr mice. Lupus 19(13):1502\u20131514","journal-title":"Lupus"},{"issue":"1","key":"2754_CR39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/scd.2009.0495","volume":"20","author":"Y Chen","year":"2011","unstructured":"Chen Y, Qian H, Zhu W et al (2011) Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev 20(1):103\u2013113","journal-title":"Stem Cells Dev"},{"issue":"11","key":"2754_CR40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/CS20110108","volume":"121","author":"S Villanueva","year":"2011","unstructured":"Villanueva S, Ewertz E, Carri\u00f3n F et al (2011) Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model. Clin Sci (Lond) 121(11):489\u2013499","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"2754_CR41","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/stem.214","volume":"27","author":"P Semedo","year":"2009","unstructured":"Semedo P, Correa-Costa M, Antonio Cenedeze M et al (2009) Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27(12):3063\u20133073","journal-title":"Stem Cells"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2754-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2754-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:24:10Z","timestamp":1649931850000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2754-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2754"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2754-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]}}}